Research and Development
10 Things to Know About Monoclonal Antibodies
CSL Behring made three recent announcements related to medicines known as “mabs.”
Hopes and Fears About Sharing Medical Data
Study: More than 2,000 rare disease patients say they’re willing to share personal medical data to spur innovation, but they …
Everyone Has a Plan Until Everything Changes
A research cardiologist at CSL Behring chronicles how the world of science is rolling forward, despite a global pandemic.
5 Things To Know About Hemophilia B
Hemophilia B patients are missing clotting Factor IX but treatments have come a long way - with more innovation in progress.
Celebrating Research While Sports Are on Hold
CSL Behring-sponsored Uplifting Athletes event provides $100,000+ in research grants.
Three Dad Stories
Every father plays his part a little differently. We checked in with a patient, a rare disease researcher and a CSL Behring l…
An All-Too Common Rare Disease
Sickle cell disease patients have been waiting a long time for a breakthrough; CSL Behring’s expert on what’s next for those …
Listen: Why We Do Clinical Trials
Podcast explores why clinical trials are so essential to advancements for patients.
Two Grants Awarded In Transplant Medicine
Work in this transformative area of medicine continues amid the COVID-19 pandemic.
New Leader Takes Over at BIO
During a pandemic, the global biotech organization hires Dr. Michelle McMurry-Heath to tell the story of science.